Editas Medicine Ownership | Who Owns Editas Medicine?

Overview Forecast RevenueFinancials Chart

Editas Medicine Ownership Summary

Editas Medicine is owned by 43.61% institutional investors, 0.27% insiders, and 56.12% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.38% of EDIT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.12% of its assets in Editas Medicine shares.

EDIT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Editas Medicine	43.61%	0.27%	56.12%
Sector	Healthcare Stocks	232.51%	10.72%	-143.22%
Industry	Biotech Stocks	384.55%	10.58%	-295.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	9.35M	10.38%	$19.16M
Blackrock	7.78M	9.50%	$36.34M
Vanguard group	8.21M	9.11%	$16.83M
Renaissance	3.04M	3.37%	$6.23M
Millennium management	2.75M	3.33%	$3.49M
Geode capital management	2.28M	2.54%	$4.68M
State street	1.93M	2.28%	$6.68M
Nuveen	1.98M	2.19%	$4.05M
Two sigma investments, lp	1.58M	1.88%	$5.50M
Two sigma advisers, lp	1.21M	1.43%	$4.18M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Green alpha advisors	161.12K	0.30%	$330.30K
Gsa capital partners llp	568.81K	0.10%	$1.17M
Entrypoint capital	84.55K	0.07%	$173.34K
Xtx topco	260.11K	0.05%	$902.59K
Kennedy capital management	565.64K	0.04%	$1.96M
Hennion & walsh asset management	279.53K	0.02%	$573.04K
Susquehanna portfolio strategies	308.33K	0.02%	$1.07M
R squared	14.37K	0.01%	$29.45K
Dlk investment management	16.62K	0.01%	$34.07K
Thrive wealth management	33.50K	0.01%	$68.67K

Top Buyers

Holder	Shares	% Assets	Change
Renaissance	3.04M	0.01%	1.76M
Blackrock funding, inc. /de	9.35M	0.00%	1.33M
Vanguard group	8.21M	0.00%	1.24M
Aqr capital management	1.07M	0.00%	693.96K
Jane street group	1.18M	0.00%	659.99K

Top Sellers

Holder	Shares	% Assets	Change
Deep track capital, lp	-	-	-4.90M
Ubs asset management americas	-	-	-2.60M
Avidity partners management lp	-	-	-1.47M
Balyasny asset management	-	-	-1.30M
Pictet asset management sa	-	-	-1.16M

New Positions

Holder	Shares	% Assets	Change	Value
Walleye capital	393.83K	0.01%	393.83K	$1.37M
Susquehanna portfolio strategies	308.33K	0.02%	308.33K	$1.07M
Wellington management group llp	295.26K	0.00%	295.26K	$1.02M
Ameriprise financial	188.14K	0.00%	188.14K	$652.86M
Entrypoint capital	84.55K	0.07%	84.55K	$173.34K

Sold Out

Holder	Change
Gps wealth strategies group	-2.00
Pacific capital wealth advisors	-5.00
Sittner & nelson	-6.00
Baldwin brothers llc/ma	-8.00
Innealta capital	-15.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	163	-20.87%	39,288,742	-8.85%	43	1.67%	54	-28.00%	48	-17.24%
Sep 30, 2025	197	-	43,075,975	4.21%	51	2.13%	69	-9.21%	57	11.76%
Jun 30, 2025	191	-3.54%	41,244,466	-6.30%	48	1.74%	72	-	52	-8.77%
Mar 31, 2025	196	-6.67%	44,003,328	-13.78%	52	1.38%	69	-27.37%	59	-1.67%
Dec 31, 2024	94	-60.17%	19,933,396	-63.85%	24	0.54%	38	-62.00%	22	-65.63%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	2.59M	3.12%	-
Vanguard Total Stock Mkt Idx Inv	2.54M	2.90%	-55.93K
iShares Russell 2000 ETF	2.07M	2.30%	-
Vanguard Strategic Equity Inv	1.87M	2.24%	-
Nuveen Quant Small Cap Equity R6	1.63M	1.81%	898.10K
Pictet Biopharmaceutical Mother	1.15M	1.38%	42.67K
Vanguard Small Cap Index	1.04M	1.26%	2.50K
Selectra J. Lamarck Biotech A	1.10M	1.23%	-
Fidelity Small Cap Index	848.54K	0.97%	2.54K
UBS (Lux) Digital Health Equity SB USD	800.00K	0.96%	-370.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 03, 2025	Burkly Linda	EVP, CHIEF SCIENTIFIC OFFICER	Sell	$1.54K
Dec 03, 2025	O'Neill Gilmore Neil	CEO	Sell	$12.06K
Dec 03, 2025	Parison Amy	SVP, Chief Financial Officer	Sell	$992.58
Sep 03, 2025	Burkly Linda	EVP, CHIEF SCIENTIFIC OFFICER	Sell	$1.84K
Sep 03, 2025	Parison Amy	SVP, Chief Financial Officer	Sell	$1.19K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	3
2025 Q3	-	5
2025 Q2	-	3
2025 Q1	-	3
2024 Q4	-	2

EDIT Ownership FAQ

Who Owns Editas Medicine?

Editas Medicine shareholders are primarily institutional investors at 43.61%, followed by 0.27% insiders and 56.12% retail investors. The average institutional ownership in Editas Medicine's industry, Biotech Stocks , is 384.55%, which Editas Medicine falls below.

Who owns the most shares of Editas Medicine?

Editas Medicine’s largest shareholders are Blackrock funding, inc. /de (9.35M shares, 10.38%), Blackrock (7.78M shares, 9.50%), and Vanguard group (8.21M shares, 9.11%). Together, they hold 28.98% of Editas Medicine’s total shares outstanding.

Does Blackrock own Editas Medicine?

Yes, BlackRock owns 9.50% of Editas Medicine, totaling 7.78M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 36.34M$. In the last quarter, BlackRock decreased its holdings by -50.264K shares, a -0.64% change.

Who is Editas Medicine’s biggest shareholder by percentage of total assets invested?

Green alpha advisors is Editas Medicine’s biggest shareholder by percentage of total assets invested, with 0.30% of its assets in 161.12K Editas Medicine shares, valued at 330.3K$.

Who is the top mutual fund holder of Editas Medicine shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Editas Medicine shares, with 3.12% of its total shares outstanding invested in 2.59M Editas Medicine shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools